AzTrials
AzTrials

Geriatric SyndromesKASAFNCT04545775

KArukera Study of Ageing in Foster Families

An observational study of Geriatric Syndromes, run by Centre Hospitalier Universitaire de la Guadeloupe at 1 site in Guadeloupe.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Foster care for dependent older people could be a viable alternative to nursing homes. While this type of accommodation appears to be less expensive than living in a geriatric institution, few scientific studies have been able to assess its effectiveness and efficiency. Read more about this study

Who is it for?
Ages 60 years and olderHealthy volunteers can take part
Conditions the study is for
Geriatric Syndromes
How many people
250 participants
Where
1 siteGuadeloupe
Study dates
13 Nov 2020to 13 Nov 2022
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 60 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Every elderly person living in a foster family in Guadeloupe will be invited to participate in the study.

Who may be able to join

  • participant must be over 60 years old
  • residents must live in a foster family in Guadeloupe, Saint-Martin or Saint-Barthelemy
  • residents must benefit from the French social security
  • Participant must have an identified support person
  • Participant under guardianship or curatorship if accepted by the legal guardian
  • Participant in a foreseeable short-term end-of-life situation if accepted by the legal representative or the support person

Who cannot join

  • refusal from the resident or his legal guardian to participate in the study

Trial locations and contacts

1 site in 1 country.

Roxane RV VILLENEUVE, Ph. D contact

+590690403039

roxane.villeneuve@chu-guadeloupe.fr

Denis DB BOUCAUD-MAITRE, PhD contact

+59069006956377

denis.boucaudmaitre@chu-guadeloupe.fr

Guadeloupe1 site, 1 recruiting

  • University Hospital Center of Guadeloupe

    Pointe-à-Pitre, 97159

    Roxanne RV VILLENEUVE, PhD, +590690403039, roxanne.villeneuve@chu-guadeloupe.fr

    Denis DB BOUCAUD-MAITRE, PhD, +590590934686, denis.boucaudmaitre@chu-guadeloupe.fr

    Recruiting

Other trials in Guadeloupe

About this study

Foster care for dependent older people could be a viable alternative to nursing homes. While this type of accommodation appears to be less expensive than living in a geriatric institution, few scientific studies have been able to assess its effectiveness and efficiency. In Guadeloupe, in the French West Indies, nearly 300 dependent older people are cared for by foster families. The aim of the Karukera Study of Ageing in Foster Families (KASAF) is to study the care pathways of dependent elderly people in foster care over a year. The main objective will be to obtain the annual rate of hospitalisation in this setting. The secondary objectives will be to assess hospitalisations costs, the incidence of mortality, the prevalence of geriatric syndromes, as well as the quality of life of residents and foster caregiver burnout. Ultimately, these results will be compared to a similar study in nursing homes, the KASEHPAD study (for Karukera Study of Aging in Nursing Homes).

Read the detailed description

Foster care for older people is an alternative solution to nursing homes, where the resident, while still moving out of his/her own home, is taken care of within the foster family instead of a collective setting. Foster caregivers, after getting official approval and attending a 20-hour training course, usually accommodate 1 to 3 people in exchange for a monthly fee. Their mission is to ensure the well-being of their residents, and to enable them to maintain close social and family relationships. Other professionals may also provide additional nursing care if necessary. Little is known about the characteristics of foster caregivers and their residents. Epidemiological and medico-economic data on older people in foster families are essential to assess the relevance of this type of care, and several and yet unanswered questions come to mind: what is the residents' annual hospitalization rate and the associated costs? What is the prevalence of geriatric syndromes in this population, and the incidence of mortality? What is the incidence of pneumonia, the leading cause of death and emergency hospitalization in older people? What is the quality of life of the older residents and their foster caregivers? KASAF, an epidemiological cohort, aims to answer these questions. This longitudinal study will assess the health status and medical and economic data of 250 foster family residents and their foster caregivers over a year. A similar study (KASEHPAD, for Karukera Study of Aging in Nursing Homes) will be conducted simultaneously among 500 nursing home residents, as to compare these two types of care.

The main outcome is the number of hospitalizations over a year. Local PMSI (Medicalization program of the information system) hospitals databases will provide information on hospital admissions.

250 people aged 60 and older and living in foster families in Guadeloupe will be included. Data collection will be conducted using face-to-face interviews with the participants and their foster caregivers at baseline and after 6 and 12 months, and phone interviews with the foster caregivers, after 3 and 9 months. Anthropometric measures, information on general health status and care pathways (hospitalization, medical and paramedical consultations), as well as data on medical history, cognition, nutritional status, and physical frailty will also be collected. Depressive and anxiety symptoms will also be assessed along with functional abilities (mobility, instrumental activities of daily living and activities of daily living). A systematic update of vital status (death) and care pathway will be carried out at each follow-up. Additional information on the residents' living status and potential hospitalizations will be collected after 3 and 9 months. Finally, foster caregivers will be interviewed at inclusion, after 6 months and after a year to assess their own quality of life and burnout symptoms.

This study was supported by a grant from the Conseil Départemental de la Guadeloupe, Saint-Martin and Saint-Barthélemy.

Keywords
Older people, foster family, hospitalization, geriatric syndromes, mortality, quality of life

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Hospitalization rate of the participant

    Number of hospital admissions over a year, retrieved from the local PMSI (Medicalization program of the information system) of the Hospital Center of Guadeloupe

    Measured: 12 months

Secondary outcomes (1)

  1. Length of hospital stays of the participant

    Length of hospital stays expressed as number of days and nights, retrieved from the local PMSI (Medicalization program of the information system) of the Hospital Center of Guadeloupe

    Measured: 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Sep 2020
  2. Study start13 Nov 2020
  3. Primary completion13 May 2021 (estimated)
  4. Study completion13 Nov 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
250 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04545775
Sponsor's protocol ID
PAP_RIPH3_2020/01
Other IDs
2020-A00620-39
Acronym
KASAF
Status last verified
Feb 2021
First submitted
4 Sep 2020
Last updated
9 Feb 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Boucaud-Maitre D, Chaumont H, Dartigues JF, Lannuzel A, Tabue-Teguo M. Parkinsonian syndromes in institutionalized older adults in the French Caribbean: Clinical characteristics and one-year mortality. Parkinsonism Relat Disord. 2026 Aug;149:108403. doi: 10.1016/j.parkreldis.2026.108403. Epub 2026 Jun 22.

    PubMed 42330831

  • Boucaud-Maitre D, Simo N, Villeneuve R, Bonnet M, Drame M, Tabue-Teguo M. Comparison of quality of life of older adults living in foster families versus nursing homes. Results from the KASA studies. J Nutr Health Aging. 2024 Oct;28(10):100358. doi: 10.1016/j.jnha.2024.100358. Epub 2024 Sep 7.

    PubMed 39244789

  • Boucaud-Maitre D, Villeneuve R, Rambhojan C, Simo-Tabue N, Thibault N, Rinaldo L, Dartigues JF, Drame M, Amieva H, Tabue-Teguo M. Clinical Characteristics of Older Adults Living in Foster Families in the French West Indies: Baseline Screening of the KArukera Study of Aging in Foster Families (KASAF) Cohort. Innov Aging. 2024 Jun 28;8(7):igae063. doi: 10.1093/geroni/igae063. eCollection 2024.

    PubMed 39087204

  • Boucaud-Maitre D, Villeneuve R, Simo-Tabue N, Dartigues JF, Amieva H, Tabue-Teguo M. The Health Care Trajectories of Older People in Foster Families: Protocol for an Observational Study. JMIR Res Protoc. 2023 Feb 8;12:e40604. doi: 10.2196/40604.

    PubMed 36753315

Questions about this trial

What is this clinical trial studying?

An observational study of Geriatric Syndromes, run by Centre Hospitalier Universitaire de la Guadeloupe at 1 site in Guadeloupe.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 9 Feb 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Guadeloupe. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Roxane RV VILLENEUVE, Ph. D (+590690403039, roxane.villeneuve@chu-guadeloupe.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Hospitalization rate of the participant (time frame: 12 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04545775, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Feb 2021.

AzTrials uses cookies for analytics and advertising. You can accept or reject them; the site works either way. Privacy Policy.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in